LISA PRIMM: Open Payments
NPI 1053507798 · LEXINGTON, KY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$381 in 22 payments from 8 companies in 2025. Trend: 2023 $634 · 2024 $454 · 2025 $381
Food & beverage: $381
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc | 9 | $135 |
| ABBVIE INC. | 4 | $80 |
| PFIZER INC. | 3 | $50 |
| AstraZeneca Pharmaceuticals LP | 2 | $32 |
| Otsuka America Pharmaceutical, Inc. | 1 | $27 |
| Amgen Inc. | 1 | $24 |
| Lilly USA, LLC | 1 | $19 |
| GlaxoSmithKline, LLC. | 1 | $15 |
Products named: Ozempic, PREVNAR 20, QULIPTA, Wegovy, UBRELVY, REXULTI, REPATHA, MOUNJARO.
Industry payments across KY — which companies pay providers there.
